Diabasens
Natural health product licensed in Canada
- Licence holder
- Innovus Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80090950
- Status
- Inactive licence
- Licence date
- 26 February 2019
- Revision date
- 17 August 2022
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Capsicum annuum Source : Fruit Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 7.5 milligramme Potency : 0.075 % Capsaicin | 0.075 % |
Non-medicinal ingredients
Limonène, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Eau purifiée, Alcool benzylique, Huile d'Amande, EDTA de tétrasodium, Sorbitol Solution, Huile de ricin hydrogénée de PEG-40, Benzoate de benzyle, L-Citrulline, Triéthanolamine, Alcool isopropylique, NA, Huile essentielle d'écorce de Cinnamomum Zeylanicum, Propylène glycol, L-arginine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Crème | minimum: 3 days ; maximum: 4 days |
Uses authorised in Canada
Used to relieve cutaneous pain associated with conditions such as post-herpetic neuralgia and diabetic neuropathy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. For external use only. Avoid contact with the eyes and mucous membranes. Do not apply to wounds or damaged skin. Do not tightly bandage. Do not apply with external heat, such as an electric heating pad, as this may result in excessive skin irritation or skin burn.
- Effets indésirables connus
Headache, erythema, redness, rashes and/or burning discomfort, and hypersensitivity have been known to occur.
Source
Official Health Canada record, licence 80090950
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging